Literature DB >> 8547529

Prevalence of Helicobacter pylori in non-ulcer dyspepsia.

M Buckley1, C O'Morain.   

Abstract

Dyspepsia is a poorly understood term that is used to describe symptoms that originate in the upper gastrointestinal tract. There is increasing evidence that Helicobacter pylori infection plays an aetiological role in some forms of dyspepsia. H. pylori infection is more common in dyspeptic patients than asymptomatic controls. Clinical trials of the benefit of H. pylori eradication therapy in non-ulcer dyspepsia have given conflicting results. This may be due to methodological flaws in the studies to date. Trials in non-ulcer dyspepsia may have several end-points. Future studies should be long-term, placebo-controlled, double-blind, and use a validated symptom questionnaire. Acid secretion studies demonstrate acid hypersecretion in non-ulcer dyspepsia that is intermediate between that seen in duodenal ulcers and asymptomatic carriers. This suggests that H. pylori gastritis represents a spectrum of disease that includes duodenal ulceration, whose natural history is one of relapses and remissions, and non-ulcer dyspepsia.

Entities:  

Mesh:

Year:  1995        PMID: 8547529

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

1.  Effect of Helicobacter pylori infection on gastric emptying and gastrointestinal hormones in dyspeptic and healthy subjects.

Authors:  M Chiloiro; F Russo; G Riezzo; C Leoci; C Clemente; C Messa; A Di Leo
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.

Authors:  Yuqin Li; Xiayue Huang; Linhua Yao; Ruihua Shi; Guoxin Zhang
Journal:  Wien Klin Wochenschr       Date:  2010-07-16       Impact factor: 1.704

Review 3.  Formulary management of proton pump inhibitors.

Authors:  M F Byrne; F E Murray
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

4.  Helicobacter pylori eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy intervention.

Authors:  Victor J Stevens; Robert J Shneidman; Richard E Johnson; Myde Boles; Paul E Steele; Nancy L Lee
Journal:  West J Med       Date:  2002-03

5.  Density of gastric Helicobacter pylori colonization is not associated with occurrence of dyspeptic symptoms.

Authors:  B Braden; W F Caspary; B Lembcke
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

Review 6.  Helicobacter pylori: the Middle East scenario.

Authors:  B H Novis; G Gabay; T Naftali
Journal:  Yale J Biol Med       Date:  1998 Mar-Apr

Review 7.  Kyoto global consensus report on Helicobacter pylori gastritis.

Authors:  Kentaro Sugano; Jan Tack; Ernst J Kuipers; David Y Graham; Emad M El-Omar; Soichiro Miura; Ken Haruma; Masahiro Asaka; Naomi Uemura; Peter Malfertheiner
Journal:  Gut       Date:  2015-07-17       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.